ArticlemedRxiv : the preprint server for health sciences2025
Functional Evidence for Substantia Nigra Pars Reticulata Involvement in Auditory Verbal Hallucinations in Treatment-Resistant Schizophrenia.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
14 authors.
Funding
Abstract
Auditory verbal hallucinations (AVH) in treatment-resistant schizophrenia (TR SZ) are often unresponsive to pharmacologic interventions, necessitating novel therapeutic approaches. We report a case of a patient with persistent AVH who underwent deep brain stimulation (DBS) of the substantia nigra pars reticulata (SNr). To investigate the neurophysiological effects of SNr stimulation on cortical activity during AVH, we performed intraoperative electrocorticography (ECoG) over the left inferior parietal cortex using a 63-channel grid. Real-time recordings captured episodes of AVH and revealed elevated theta-gamma phase-amplitude coupling (PAC), a marker of aberrant cortical synchronization. DBS intervention resulted in normalization of PAC dynamics, with both average PAC and spatial distribution returning to non-AVH levels. Clinically, SNr DBS was associated with a 64% reduction in AVH frequency. These findings provide the first real-time functional evidence linking SNr activity to cortical oscillatory changes underlying AVH. This case supports the potential of SNr as a novel neuromodulatory target in TR SZ and highlights theta-gamma PAC as a candidate biomarker for mechanistic tracking of AVH symptomatology.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.